Neoadjuvant Immunotherapy Appears Promising for Muscle-Invasive Bladder Cancer
Neoadjuvant immunotherapy is an attractive alternative to chemotherapy for patients with localized MIBC because of its lower toxicity profile.
Diagnosis & Disease Information
Risk Factors Identified for Kidney Function Decline After Radical Cystectomy
Patient comorbidities were among the significant risk factors for kidney function decline.
Obesity, Diabetes Up Surgical Infection Risk After Radical Cystectomy
Investigators report findings from a retrospective study of 13,081 patients undergoing radical cystectomy.
UTI Risk Not Raised by Early Ureteral Stent Removal After Radical Cystectomy
The optimal duration of antibiotic prophylaxis is still unknown.
Chemoradiation, Cystectomy Offer Similar Survival in Octogenarians with MIBC
Study findings suggest that chemoradiation therapy could be considered an alternative to surgery in this patient population.
Urologic Oncologists Seldom Perform Female Organ- and Nerve-Sparing Radical Cystectomy
Provider training on female reproductive organ-sparing and nerve-sparing radical cystectomy needs to improve, according to investigators.
Radical Cystectomy Increases Risks for Thromboembolic Events
Swedish studies reveal significantly elevated risks for myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.
Prostate Cancer Found at Radical Cystectomy Usually Clinically Insignificant
Findings are from a case series of men who underwent cystoprostatectomy in China.
Neoadjuvant Chemotherapy-Induced AKI Tied With Worse MIBC Outcomes
Acute kidney injury frequently occurs during neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Opioid Prescription Can Be Eliminated After Urologic Cancer Surgery
Postoperative opioid prescriptions are associated with delayed recovery, perioperative complications, and opioid misuse, investigators noted.
- Loading...
Loading...
Next post in Urology
Loading... 
Loading...